• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药用植物及其对心理健康中肠道微生物组的影响:系统评价。

Medicinal Plants and Their Impact on the Gut Microbiome in Mental Health: A Systematic Review.

机构信息

Department of Pharmacognosy, Institute of Pharmaceutical Sciences, University of Graz, Beethovenstraße 8, 8010 Graz, Austria.

BioTechMed, Mozartgasse 12, 8010 Graz, Austria.

出版信息

Nutrients. 2022 May 18;14(10):2111. doi: 10.3390/nu14102111.

DOI:10.3390/nu14102111
PMID:35631252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9144835/
Abstract

BACKGROUND

Various neurocognitive and mental health-related conditions have been associated with the gut microbiome, implicating a microbiome-gut-brain axis (MGBA). The aim of this systematic review was to identify, categorize, and review clinical evidence supporting medicinal plants for the treatment of mental disorders and studies on their interactions with the gut microbiota.

METHODS

This review included medicinal plants for which clinical studies on depression, sleeping disorders, anxiety, or cognitive dysfunction as well as scientific evidence of interaction with the gut microbiome were available. The studies were reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.

RESULTS

Eighty-five studies met the inclusion criteria and covered thirty mental health-related medicinal plants with data on interaction with the gut microbiome.

CONCLUSION

Only a few studies have been specifically designed to assess how herbal preparations affect MGBA-related targets or pathways. However, many studies provide hints of a possible interaction with the MGBA, such as an increased abundance of health-beneficial microorganisms, anti-inflammatory effects, or MGBA-related pathway effects by gut microbial metabolites. Data for , , and indicate that the interaction of their constituents with the gut microbiota could mediate mental health benefits. Studies specifically assessing the effects on MGBA-related pathways are still required for most medicinal plants.

摘要

背景

各种与神经认知和心理健康相关的病症都与肠道微生物群有关,这暗示了一个微生物群-肠道-大脑轴(MGBA)的存在。本系统综述的目的是确定、分类和综述支持药用植物治疗精神障碍的临床证据,以及研究它们与肠道微生物群相互作用的证据。

方法

本综述纳入了有治疗抑郁症、睡眠障碍、焦虑或认知功能障碍的临床研究以及与肠道微生物群相互作用的科学证据的药用植物。研究报告使用了系统评价和荟萃分析的首选报告项目(PRISMA)声明。

结果

85 项研究符合纳入标准,涵盖了 30 种与心理健康相关的药用植物,并有关于与肠道微生物群相互作用的数据。

结论

只有少数研究专门设计用于评估草药制剂如何影响 MGBA 相关的靶点或途径。然而,许多研究提供了与 MGBA 可能相互作用的线索,例如有益微生物的丰度增加、抗炎作用,或肠道微生物代谢物对 MGBA 相关途径的影响。、和的数据表明,其成分与肠道微生物群的相互作用可能介导了心理健康的益处。对于大多数药用植物,仍需要进行专门评估对 MGBA 相关途径影响的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf95/9144835/200740dd17aa/nutrients-14-02111-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf95/9144835/9e3890101a8a/nutrients-14-02111-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf95/9144835/68a56cae4f08/nutrients-14-02111-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf95/9144835/8f16f8ae54d0/nutrients-14-02111-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf95/9144835/54b966a2dab2/nutrients-14-02111-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf95/9144835/200740dd17aa/nutrients-14-02111-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf95/9144835/9e3890101a8a/nutrients-14-02111-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf95/9144835/68a56cae4f08/nutrients-14-02111-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf95/9144835/8f16f8ae54d0/nutrients-14-02111-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf95/9144835/54b966a2dab2/nutrients-14-02111-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf95/9144835/200740dd17aa/nutrients-14-02111-g005.jpg

相似文献

1
Medicinal Plants and Their Impact on the Gut Microbiome in Mental Health: A Systematic Review.药用植物及其对心理健康中肠道微生物组的影响:系统评价。
Nutrients. 2022 May 18;14(10):2111. doi: 10.3390/nu14102111.
2
Control interventions in randomised trials among people with mental health disorders.精神障碍患者随机试验中的对照干预措施。
Cochrane Database Syst Rev. 2022 Apr 4;4(4):MR000050. doi: 10.1002/14651858.MR000050.pub2.
3
Shared decision-making interventions for people with mental health conditions.心理健康问题患者的共同决策干预措施。
Cochrane Database Syst Rev. 2022 Nov 11;11(11):CD007297. doi: 10.1002/14651858.CD007297.pub3.
4
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.固体器官移植受者的共生元、益生元和益生菌。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.
5
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
6
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
7
Parent-training programmes for improving maternal psychosocial health.改善孕产妇心理社会健康的家长培训项目。
Cochrane Database Syst Rev. 2004(1):CD002020. doi: 10.1002/14651858.CD002020.pub2.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
Exercise interventions and patient beliefs for people with hip, knee or hip and knee osteoarthritis: a mixed methods review.髋、膝或髋膝骨关节炎患者的运动干预和患者信念:一项混合方法综述
Cochrane Database Syst Rev. 2018 Apr 17;4(4):CD010842. doi: 10.1002/14651858.CD010842.pub2.

引用本文的文献

1
Natural Compounds and Their Potential in Eating-Related Aspects of Mental Health Disorders.天然化合物及其在饮食相关心理健康障碍方面的潜力。
Nutrients. 2025 Jul 21;17(14):2383. doi: 10.3390/nu17142383.
2
Neurosteroids, Microbiota, and Neuroinflammation: Mechanistic Insights and Therapeutic Perspectives.神经甾体、微生物群与神经炎症:机制见解与治疗前景
Int J Mol Sci. 2025 Jul 21;26(14):7023. doi: 10.3390/ijms26147023.
3
Multimodal Interventions Targeting Gut Microbiota and Microbial Metabolites in Cognitive Impairment.针对认知障碍中肠道微生物群和微生物代谢物的多模式干预措施。

本文引用的文献

1
Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation.肠道微生物群:人参治疗多种疾病的靶点及人参皂苷的转化。
Front Cell Infect Microbiol. 2022 Apr 25;12:853981. doi: 10.3389/fcimb.2022.853981. eCollection 2022.
2
Urolithins: The Colon Microbiota Metabolites as Endocrine Modulators: Prospects and Perspectives.尿石素:作为内分泌调节剂的结肠微生物群代谢产物:前景与展望
Front Nutr. 2022 Feb 2;8:800990. doi: 10.3389/fnut.2021.800990. eCollection 2021.
3
Exploring the Impact of Flavonoids on Symptoms of Depression: A Systematic Review and Meta-Analysis.
Cureus. 2025 Jun 10;17(6):e85688. doi: 10.7759/cureus.85688. eCollection 2025 Jun.
4
Pomegranate-Derived Exosome-Like Nanovesicles Containing Ellagic Acid Alleviate Gut Leakage and Liver Injury in MASLD.含有鞣花酸的石榴衍生外泌体样纳米囊泡可减轻非酒精性脂肪性肝炎相关肝纤维化中的肠渗漏和肝损伤。
Food Sci Nutr. 2025 Apr 10;13(4):e70088. doi: 10.1002/fsn3.70088. eCollection 2025 Apr.
5
Advances in the research of comorbid insomnia and depression: mechanisms, impacts, and interventions.共病性失眠与抑郁的研究进展:机制、影响及干预措施
Front Psychiatry. 2025 Mar 26;16:1468212. doi: 10.3389/fpsyt.2025.1468212. eCollection 2025.
6
Anxiolytic, Antidepressant and Healthy Sleep-Promoting Potential of Rosmarinic Acid: Mechanisms and Molecular Targets.迷迭香酸的抗焦虑、抗抑郁及促进健康睡眠的潜力:作用机制与分子靶点
Neuropsychiatr Dis Treat. 2025 Mar 20;21:641-661. doi: 10.2147/NDT.S501597. eCollection 2025.
7
Impact of curcumin on gut microbiome.姜黄素对肠道微生物群的影响。
World J Exp Med. 2025 Mar 20;15(1):100275. doi: 10.5493/wjem.v15.i1.100275.
8
From bugs to brain: unravelling the GABA signalling networks in the brain-gut-microbiome axis.从微生物到大脑:解析脑-肠-微生物群轴中的γ-氨基丁酸信号网络
Brain. 2025 May 13;148(5):1479-1506. doi: 10.1093/brain/awae413.
9
The Causal Effects between Mood Swings and Gastrointestinal Diseases: A Mendelian Randomization Study.情绪波动与胃肠道疾病之间的因果关系:一项孟德尔随机化研究。
Alpha Psychiatry. 2024 Aug 1;25(4):533-540. doi: 10.5152/alphapsychiatry.2024.241688. eCollection 2024 Aug.
10
Innovative treatments for obesity and NAFLD: A bibliometric study on antioxidants, herbs, phytochemicals, and natural compounds.肥胖症和非酒精性脂肪性肝病的创新疗法:关于抗氧化剂、草药、植物化学物质和天然化合物的文献计量学研究
Heliyon. 2024 Aug 8;10(16):e35498. doi: 10.1016/j.heliyon.2024.e35498. eCollection 2024 Aug 30.
探索类黄酮对抑郁症症状的影响:一项系统评价与荟萃分析
Antioxidants (Basel). 2021 Oct 20;10(11):1644. doi: 10.3390/antiox10111644.
4
Gut Microbiota: Novel Therapeutic Target of Ginsenosides for the Treatment of Obesity and Its Complications.肠道微生物群:人参皂苷治疗肥胖及其并发症的新型治疗靶点。
Front Pharmacol. 2021 Aug 27;12:731288. doi: 10.3389/fphar.2021.731288. eCollection 2021.
5
Gut Microbiota and Pathophysiology of Depressive Disorder.肠道微生物群与抑郁症的病理生理学
Ann Nutr Metab. 2021;77 Suppl 2:11-20. doi: 10.1159/000518274. Epub 2021 Jul 28.
6
Polyphenol-Mediated Gut Microbiota Modulation: Toward Prebiotics and Further.多酚介导的肠道微生物群调节:迈向益生元及其他。
Front Nutr. 2021 Jun 28;8:689456. doi: 10.3389/fnut.2021.689456. eCollection 2021.
7
Dietary Polyphenols in Metabolic and Neurodegenerative Diseases: Molecular Targets in Autophagy and Biological Effects.代谢性疾病和神经退行性疾病中的膳食多酚:自噬中的分子靶点及生物学效应
Antioxidants (Basel). 2021 Jan 20;10(2):142. doi: 10.3390/antiox10020142.
8
Improvements in estrogen deficiency-induced hypercholesterolemia by Hypericum perforatum L. extract are associated with gut microbiota and related metabolites in ovariectomized (OVX) rats.贯叶连翘提取物改善去卵巢(OVX)大鼠雌激素缺乏诱导的高胆固醇血症与肠道微生物群及其相关代谢物有关。
Biomed Pharmacother. 2021 Mar;135:111131. doi: 10.1016/j.biopha.2020.111131. Epub 2020 Dec 28.
9
The intervention of unique plant polysaccharides - Dietary fiber on depression from the gut-brain axis.独特植物多糖(膳食纤维)对肠脑轴相关抑郁症的干预作用。
Int J Biol Macromol. 2021 Feb 15;170:336-342. doi: 10.1016/j.ijbiomac.2020.12.164. Epub 2020 Dec 26.
10
Purple-leaf tea (Camellia sinensis L.) ameliorates high-fat diet induced obesity and metabolic disorder through the modulation of the gut microbiota in mice.紫叶茶(Camellia sinensis L.)通过调节小鼠肠道微生物群改善高脂肪饮食诱导的肥胖和代谢紊乱。
BMC Complement Med Ther. 2020 Dec 10;20(1):376. doi: 10.1186/s12906-020-03171-4.